AAAAAA

   
Results: 1-12 |
Results: 12
ELEVATED TISSUE FACTOR AND TISSUE FACTOR PATHWAY INHIBITOR CIRCULATING LEVELS IN ISCHEMIC-HEART-DISEASE PATIENTS
Authors: FALCIANI M GORI AM FEDI S CHIARUGI L SIMONETTI I DABIZZI RP PRISCO D PEPE G ABBATE R GENSINI GF SERNERI GGN
Citation: M. Falciani et al., ELEVATED TISSUE FACTOR AND TISSUE FACTOR PATHWAY INHIBITOR CIRCULATING LEVELS IN ISCHEMIC-HEART-DISEASE PATIENTS, Thrombosis and haemostasis, 79(3), 1998, pp. 495-499
IS HYPERHOMOCYSTEINEMIA A RISK FACTOR FOR RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
Authors: MARCUCCI R PEPE G FEDERICI G CORTESE C PASTORE A BRUNELLI T CHIARUGI L PRISCO D ABBATE R GENSINI GF
Citation: R. Marcucci et al., IS HYPERHOMOCYSTEINEMIA A RISK FACTOR FOR RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), Thrombosis research, 91(3), 1998, pp. 236-236
RESTENOSIS AND HEMOSTATIC ALTERATIONS AFTER PTCA
Authors: CAPANNI M ANTONUCCI E CHIARUGI L BODDI V COMEGLIO P PRISCO D ILARI I GIUSTI B GIURLANI L SIMONETTI I GENSINI GF
Citation: M. Capanni et al., RESTENOSIS AND HEMOSTATIC ALTERATIONS AFTER PTCA, Thrombosis research, 91(3), 1998, pp. 251-251
ROLE OF LP(A) AND ACL IN THE OCCURRENCE OF RESTENOSIS AFTER PTCA
Authors: CHIARUGI L ANTONUCCI E CAPANNI M BODDI V GIUSTI B PRISCO D COMEGLIO P MARGHERI M SIMONE I GENSINI GF ABBATE R
Citation: L. Chiarugi et al., ROLE OF LP(A) AND ACL IN THE OCCURRENCE OF RESTENOSIS AFTER PTCA, Thrombosis research, 91(3), 1998, pp. 252-252
EFFECTS OF CORONARY ANGIOGRAPHY ON HEMOSTATIC SYSTEM
Authors: ANTONUCCI E CAPANNI M CHIARUGI L GIGLIOLI C GIUSTI B POLI D PRISCO D BRUNELLI T GENSINI GF
Citation: E. Antonucci et al., EFFECTS OF CORONARY ANGIOGRAPHY ON HEMOSTATIC SYSTEM, Thrombosis research, 91(3), 1998, pp. 253-253
LOW-DOSE HEPARIN PRETREATMENT IS NOT ABLE TO PREVENT CLOTTING ACTIVATION DURING CORONARY ANGIOGRAPHY
Authors: CAPANNI M ANTONUCCI E CHIARUGI L GIGLIOLI C MARGHERI M SIMONETTI I PRISCO D ABBATE R GENSINI GF
Citation: M. Capanni et al., LOW-DOSE HEPARIN PRETREATMENT IS NOT ABLE TO PREVENT CLOTTING ACTIVATION DURING CORONARY ANGIOGRAPHY, Thrombosis research, 91(3), 1998, pp. 151-153
THE TISSUE FACTOR TISSUE FACTOR PATHWAY INHIBITOR SYSTEM IN PATIENTS WITH ISCHEMIC-HEART-DISEASE
Authors: FALCIANI M GORI AM FEDI S CHIARUGI L SIMONETTI I DABIZZI P PRISCO D ABBATE R GENSINI GF SERNERI GGN
Citation: M. Falciani et al., THE TISSUE FACTOR TISSUE FACTOR PATHWAY INHIBITOR SYSTEM IN PATIENTS WITH ISCHEMIC-HEART-DISEASE, Thrombosis and haemostasis, 1997, pp. 675-675
ARE ANTIPHOSPHOLIPID ANTIBODIES MARKERS OF RISK OF RESTENOSIS AFTER PTCA
Authors: CHIARUGI L PRISCO D SIMONETTI I GIGLIOLI C FEDI S ABBATE R ANTONUCCI E CAPANNI M FARSI A GENSINI GF
Citation: L. Chiarugi et al., ARE ANTIPHOSPHOLIPID ANTIBODIES MARKERS OF RISK OF RESTENOSIS AFTER PTCA, Thrombosis and haemostasis, 1997, pp. 1374-1374
HIGH-LEVELS OF LP(A) ARE A RISK FACTOR FOR RESTENOSIS AFTER PTCA
Authors: CAPANNI M PRISCO D SIMONETTI I MARGHERI M GIGLIOLI C ANTONUCCI E CHIARUGI L MARCUCCI R ABBATE R GENSINI GF
Citation: M. Capanni et al., HIGH-LEVELS OF LP(A) ARE A RISK FACTOR FOR RESTENOSIS AFTER PTCA, Thrombosis and haemostasis, 1997, pp. 2944-2944
PLATELET ACTIVATION DOES OCCUR AFTER PTCA EVEN IN PATIENTS ON ASPIRINWITHOUT FUTURE ACUTE ISCHEMIC EVENTS
Authors: PRISCO D SIMONETTI I DABIZZI RP MARGHERI M GIGLIOLI C ANTONUCCI E CAPANNI M CHIARUGI L FEDI S GENSINI GF
Citation: D. Prisco et al., PLATELET ACTIVATION DOES OCCUR AFTER PTCA EVEN IN PATIENTS ON ASPIRINWITHOUT FUTURE ACUTE ISCHEMIC EVENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1041-1041
CHANGES IN D-DIMER LEVELS DURING PREGNANCY
Authors: FRANCALANCI I CELLAI AP ALESSANDRELLO LT COMEGLIO P BRUNELLI T FILIPPINI M BANDINELLI B ILARI I ZARONE N CHIARUGI L
Citation: I. Francalanci et al., CHANGES IN D-DIMER LEVELS DURING PREGNANCY, Thrombosis and haemostasis, 73(6), 1995, pp. 1303-1303
EFFECTS OF HORMONE REPLACEMENT THERAPY ON LIPOPROTEIN(A) AND FIBRINOLYSIS SYSTEM
Authors: MICHELI S PINTO S FEDI S ROSATI D CELLAI AP CHIARUGI L CACIOLLI S GORI AM BRUNI V ABBATE R
Citation: S. Micheli et al., EFFECTS OF HORMONE REPLACEMENT THERAPY ON LIPOPROTEIN(A) AND FIBRINOLYSIS SYSTEM, Thrombosis and haemostasis, 73(6), 1995, pp. 1381-1381
Risultati: 1-12 |